STAT+: JPM 2024: FogPharma’s new CEO, Mathai Mamman, unveils ‘contrarian’ plan in oncology

FogPharma CEO Mathai Mammen is taking the stage at #JPM24 Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks